{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:52:50Z","timestamp":1771041170574,"version":"3.50.1"},"reference-count":9,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,8,16]]},"DOI":"10.1182\/blood-2012-06-434019","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T12:41:29Z","timestamp":1345120889000},"page":"1351-1352","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["CCR1 blockade and myeloma bone disease"],"prefix":"10.1182","volume":"120","author":[{"given":"Michael","family":"Sebag","sequence":"first","affiliation":[{"name":"McGILL UNIVERSITY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"7","key":"2019111809250488900_B1","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1182\/blood-2011-10-384784","article-title":"CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease.","volume":"120","author":"Dairaghi","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2019111809250488900_B2","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1158\/1078-0432.CCR-10-1804","article-title":"Advances in the biology and treatment of bone disease in multiple myeloma.","volume":"17","author":"Raje","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"14","key":"2019111809250488900_B3","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1200\/JCO.2010.32.5449","article-title":"Advances in imaging and the management of myeloma bone disease.","volume":"29","author":"Terpos","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111809250488900_B4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation.","volume":"354","author":"Charo","year":"2006","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111809250488900_B5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.exphem.2010.06.012","article-title":"The cytokine\/chemokine pattern in the bone marrow environment of multiple myeloma patients.","volume":"38","author":"Cao","year":"2010","journal-title":"Exp Hematol"},{"issue":"10","key":"2019111809250488900_B6","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1182\/blood-2006-04-017087","article-title":"MIP-1\u03b1lpha (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma.","volume":"108","author":"Masih-Khan","year":"2006","journal-title":"Blood"},{"issue":"9","key":"2019111809250488900_B7","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1517\/14728222.2011.586634","article-title":"CCR1 as a target for multiple myeloma.","volume":"15","author":"Vallet","year":"2011","journal-title":"Expert Opin Ther Targets"},{"issue":"5-6","key":"2019111809250488900_B8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10585-006-9038-6","article-title":"Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.","volume":"23","author":"Menu","year":"2006","journal-title":"Clin Exp Metastasis"},{"issue":"23","key":"2019111809250488900_B9","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1182\/blood-2011-11-392522","article-title":"Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial.","volume":"119","author":"Morgan","year":"2012","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/7\/1351\/1498957\/zh803312001351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/7\/1351\/1498957\/zh803312001351.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T10:26:38Z","timestamp":1574072798000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/7\/1351\/30748\/CCR1-blockade-and-myeloma-bone-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,16]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,8,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-06-434019","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,16]]}}}